In this study, we detected pathogenic mutations and investigated the phenotypes of a Chinese family with OI caused by compound heterozygous mutations in BMP1. In addition, we observed the efficacy of bisphosphonates for the treatment of OI. This evidence concerns the gene BMP1 and osteogenesis imperfecta.